CY1106472T1 - Η χρηση των παραγωγων υδροξυπυριδονης στην επουλωση πληγων - Google Patents

Η χρηση των παραγωγων υδροξυπυριδονης στην επουλωση πληγων

Info

Publication number
CY1106472T1
CY1106472T1 CY20071100684T CY071100684T CY1106472T1 CY 1106472 T1 CY1106472 T1 CY 1106472T1 CY 20071100684 T CY20071100684 T CY 20071100684T CY 071100684 T CY071100684 T CY 071100684T CY 1106472 T1 CY1106472 T1 CY 1106472T1
Authority
CY
Cyprus
Prior art keywords
wound healing
hydroxypyridone derivatives
hydroxypyridone
derivatives
compounds
Prior art date
Application number
CY20071100684T
Other languages
English (en)
Inventor
Manfred Bohn
Karl Theodor Kraemer
Roland M. Wenger
Original Assignee
Sanofi-Aventis Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis Deutschland Gmbh filed Critical Sanofi-Aventis Deutschland Gmbh
Publication of CY1106472T1 publication Critical patent/CY1106472T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Η παρούσα εφεύρεση αφορά τη χρήση των ενώσεων του τύπου (I), όπου το R1, R2, R3 και το R4 έχουν τις έννοιες που δηλώνονται στις αξιώσεις, για τη θεραπεία της επούλωσης πληγών.
CY20071100684T 2002-04-20 2007-05-21 Η χρηση των παραγωγων υδροξυπυριδονης στην επουλωση πληγων CY1106472T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02008902A EP1354586A1 (en) 2002-04-20 2002-04-20 The use of hydroxpyridone-derivatives in wound healing
PCT/EP2003/003618 WO2003088966A1 (en) 2002-04-20 2003-04-08 The use of hydroxypyridone-derivatives in wound healing
EP03718739A EP1499312B1 (en) 2002-04-20 2003-04-08 The use of hydroxypyridone-derivatives in wound healing

Publications (1)

Publication Number Publication Date
CY1106472T1 true CY1106472T1 (el) 2012-01-25

Family

ID=28459510

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071100684T CY1106472T1 (el) 2002-04-20 2007-05-21 Η χρηση των παραγωγων υδροξυπυριδονης στην επουλωση πληγων

Country Status (16)

Country Link
US (1) US20040014794A1 (el)
EP (2) EP1354586A1 (el)
JP (1) JP4709489B2 (el)
AT (1) ATE357915T1 (el)
AU (1) AU2003222802B2 (el)
BR (1) BR0309403A (el)
CA (1) CA2482972C (el)
CY (1) CY1106472T1 (el)
DE (1) DE60312840T2 (el)
DK (1) DK1499312T3 (el)
ES (1) ES2282615T3 (el)
IL (1) IL164536A (el)
MX (1) MXPA04009186A (el)
PT (1) PT1499312E (el)
SI (1) SI1499312T1 (el)
WO (1) WO2003088966A1 (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8703119B2 (en) 2007-10-05 2014-04-22 Polygene Ltd. Injectable biodegradable polymer compositions for soft tissue repair and augmentation
EP2576513A1 (en) 2010-06-01 2013-04-10 Biotheryx Inc. Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating proliferative diseases
GB201509847D0 (en) * 2015-06-08 2015-07-22 Nautilus Biosciences Canada Inc Anti-dandruff agents

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1322169C (en) * 1988-04-22 1993-09-14 Hiroshi Yamazaki Ionic dressing of topical administration of drugs to wounds and burns
US5723119A (en) * 1989-07-28 1998-03-03 Schering Corporation Method for enhancing wound healing/repair with IL-4
US5728546A (en) * 1995-06-05 1998-03-17 Human Genome Sciences, Inc. Fibroblast growth factor 13
FR2737118B1 (fr) * 1995-07-28 1997-09-05 Oreal Composition dermatologique ou pharmaceutique, procede de preparation et utilisation
EP0927716B1 (en) * 1995-10-25 2003-05-07 Senju Pharmaceutical Co., Ltd. Angiogenesis inhibitor
US5811078A (en) * 1997-03-14 1998-09-22 Adolor Corporation Spray formulations of antihyperalgesic opiates and method of treating topical hyperalgesic conditions therewith
DE19802708A1 (de) * 1998-01-24 1999-07-29 Hoechst Marion Roussel De Gmbh Verwendung von hydroxypyridon-haltigen Puderzubereitungen zur Behandlung von Unterschenkel- und Druckgeschwüren
US7387779B2 (en) * 1998-06-17 2008-06-17 Beth Israel Deaconess Medical Center Anti-angiogenic proteins and fragments and methods of use thereof
SE521431C2 (sv) * 1999-12-02 2003-11-04 Sca Hygiene Prod Ab Användning av en pH-buffrande substans för att förhindra hudinfektioner orsakade av Candida Albicans
EP1397484A4 (en) * 2001-03-27 2005-05-25 Massachusetts Inst Technology METHODS AND PRODUCTS RELATED TO DIMERIZATION OF FIBROBLAST GROWTH FACTORS
WO2003018014A2 (en) * 2001-08-23 2003-03-06 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Methods of inhibiting formation of vascular channels and profileration using pyridinone derivatives

Also Published As

Publication number Publication date
IL164536A (en) 2011-11-30
CA2482972C (en) 2011-02-01
WO2003088966A1 (en) 2003-10-30
JP4709489B2 (ja) 2011-06-22
EP1354586A1 (en) 2003-10-22
CA2482972A1 (en) 2003-10-30
AU2003222802A1 (en) 2003-11-03
JP2005529875A (ja) 2005-10-06
BR0309403A (pt) 2005-02-01
ATE357915T1 (de) 2007-04-15
DE60312840D1 (de) 2007-05-10
DE60312840T2 (de) 2007-12-13
AU2003222802B2 (en) 2008-01-03
IL164536A0 (en) 2005-12-18
SI1499312T1 (sl) 2007-08-31
EP1499312B1 (en) 2007-03-28
MXPA04009186A (es) 2004-11-26
DK1499312T3 (da) 2007-07-02
EP1499312A1 (en) 2005-01-26
PT1499312E (pt) 2007-05-31
US20040014794A1 (en) 2004-01-22
ES2282615T3 (es) 2007-10-16

Similar Documents

Publication Publication Date Title
CY1105621T1 (el) Νεα ετεροκυκλικα παραγωγα φθορογλυκοζιτου, φαρμακα που περιεχουν τις ενωσεις αυτες και η χρηση τους
CY1106679T1 (el) Αζαδικυκλικες ετεροκυκλικες ενωσεις ως τροποποιητες κανναβινοειδους υποδοχεα
CY1109886T1 (el) Καινοφανεις ενωσεις ως αντι-φλεγμονωδεις, ανοσοτροποποιητικοι και αντι υπερπλαστικοι παραγοντες
CY1108067T1 (el) Υποκατεστημενα παραγωγα 2-πυριδινο-κυκλοεξανο-1,4-διαμινης
DK1864975T3 (da) Nikotinamid-derivater anvendelige som P38-inhibitorer
CY1115580T1 (el) Συνθεση και αντι-ιικη δραστηριοτητα των υποκατεστημενων παραγωγων αζαϊνδολοοξικης πιπεραζινης
DE69823344D1 (de) Substituierte benzimidazol-derivaten und ihre verwendung zur behandlung retroviraler infektionen
CY1107985T1 (el) Ccr1 ανταγωνιστες για την αγωγη μεταξυ αλλων απομυελινωτικης φλεγμονωδους νοσου
CY1109227T1 (el) Παραγωγα της 5-φαινυλο-4-μεθυλο-θειαζολ-2-υλ-αμινης ως αναστολεις των ενζυμων κινασης της φωσφατιδυλινοσιτολης 3 (p13) για την θεραπεια των φλεγμονωδων ασθενειων των αεραγωγων
CY1108522T1 (el) Μεθοδος συνθεσης της περινδοπριλης και των φαρμακευτικως αποδεκτων αλατων της
CY1108874T1 (el) ΧΡΗΣΗ ΤΩΝ ΑΝΑΣΤΟΛΕΩΝ Ι κΒ- ΚΙΝΑΣΗΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΠΟΝΟΥ
ATE302775T1 (de) Carbolinderivate
CY1110258T1 (el) Υποκατεστημενα παραγωγα c-κυκλοεξυλομεθυλαμινης
CY1110332T1 (el) Παραγωγα βενζιμιδαζολης, συνθεσεις που τα περιεχουν, παρασκευη αυτων και χρηση τους
DE60121461D1 (de) Kondensierte pyridoindolderivate
CY1106343T1 (el) Παραγωγα νικοτιναμιδιου χρησιμα σαν pde4 αναστολεις
DE60230127D1 (de) Inhibitoren von integrin alpha-v-beta-6
SE0104250D0 (sv) Heterocyclic compounds
ATE311389T1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
NO20052994L (no) Nye fosforamidderivater.
DE60112960D1 (de) Kondensierte pyridoindolderivate
SE0003476D0 (sv) Compounds
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
ATE359283T1 (de) Substituierte pyrazinonverbindungen zur behandlung von entzündungen
CY1106472T1 (el) Η χρηση των παραγωγων υδροξυπυριδονης στην επουλωση πληγων